Barely Significant
← all excerpts

Clinical Studies Using Intranasal Therapies for Parkinson's Disease: A Review.

Adv Pharm Bull · 2026 · PMC13408388 · PMID 42524014

Europe PMCDOI
1
hedged sentence
0.0679
closest p · 1.4× alpha
0.0679
boldest claim

The sentences

near-significantP < 0.0679so close (0.05 < p ≤ 0.1)
Off-hours reductions were near-significant versus baseline ( P < 0.0679) and favored intranasal versus subcutaneous ( P < 0.069). 23 Human Neural Stem Cells In this study Intranasal human neural stem cellANGE-S003 was well endured with no serious adverse events or MRI abnormalities.

also in 1,669 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.